Cyclophosphamide FDA Link Generic

Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Also Known As:

Cytoxan; Neosar; (+,- )- 2- (bis(2- Chloroethyl)amino)tetrahydro- 2H- 1,3,2- oxazaphosphorine 2-Oxide Monohydrate; B-518; Cyclophosphamide Anhydrous; Cyclophosphamide Monohydrate; Cyclophosphamide, (R)-Isomer; Cyclophosphamide, (S)-Isomer; Cyclophosphane; Cytophosphan; Cytophosphane; Endoxan; NSC-26271; Procytox; Sendoxan; B 518; B518; NSC 26271; NSC26271

Pharmalogical Action Categories:

Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunosuppressive Agents
Mutagens
Myeloablative Agonists

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473

I Nagatsuka Selected Research

I Nagatsuka Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure